Author

Richard Pushkin

Observed institutions: Actelion (United States), Cempra Pharmaceuticals (United States), University of California San Francisco Medical Center, Theravance Biopharma (United States), Achaogen (United States), Cerexa (United States)

OpenAlex ID: A5070900035

Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects

2016 · Todd A. Riccobene, Richard Pushkin, et al. · Antimicrobial Agents and Chemotherapy · 51

A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug–Drug Interaction

2016 · Richard Pushkin, Maria D. Iglesias-Ussel, et al. · Clinical Infectious Diseases · 44

Improving the Reporting of Adverse Drug Reactions in the Hospital Setting

2010 · Richard Pushkin, Lynda Frassetto, et al. · Postgraduate Medicine · 36

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

2023 · Chloe Orkin, Jean-Michel Molina, et al. · The Lancet HIV · 34

Improved Outcomes with Plazomicin (PLZ) Compared with Colistin (CST) in Patients with Bloodstream Infections (BSI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE): Results from the CARE Study

2017 · James A McKinnell, Lynn E Connolly, et al. · Open Forum Infectious Diseases · 32

First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3 -associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1

2025 · Milind Y Desai, Sherif F Nagueh, et al. · Cardiovascular Research · 25

LBO-002 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis

2025 · Naim Alkhouri, Rebecca Taub, et al. · Journal of Hepatology · 9

Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance

2015 · Richard Pushkin, Steven L. Barriere, et al. · Antimicrobial Agents and Chemotherapy · 7

Works count: 9

Citation count: 238

H-index: 7

I10-index: 6